Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVINDER S GROVER

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1194861674
CMS profile
8661
Location
DALLAS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$146,053.16

132 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Allergan, Inc. $93,629.86 89
NEW WORLD MEDICAL,INC. $27,144.17 22
Reichert, Inc. $13,500.00 5
Aerie Pharmaceuticals, Inc. $11,707.13 12
Akorn, Inc. $35.91 2
Alcon Vision LLC $21.55 1
Glaukos Corporation $14.54 1

Page 2 of 3; records 51–100 of 132 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVINDER S GROVER

NPI 1194861674 · CMS profile ID 8661

Allopathic & Osteopathic Physicians / Ophthalmology

DALLAS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 132 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1194861674?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVINDER S GROVER, NPI 1194861674, CMS profile ID 8661. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 132 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1194861674?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). DAVINDER S GROVER, NPI 1194861674, CMS profile ID 8661. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 132 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1194861674?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
DAVINDER S GROVER, NPI 1194861674, CMS profile ID 8661, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 132 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1194861674?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

132 matching records · $146,053.16 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 132 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 132.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Allergan, Inc. $18.4508/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734109 CMS
Allergan, Inc. $900.0008/03/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734107 CMS
Allergan, Inc. $1,250.0007/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734103 CMS
Allergan, Inc. $1,250.0007/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734105 CMS
Glaukos Corporation $14.5407/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753299681 CMS
Alcon Vision LLC $21.5507/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 729676525 CMS
Allergan, Inc. $1,250.0007/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734101 CMS
Allergan, Inc. $750.0007/14/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734097 CMS
Allergan, Inc. $300.0007/14/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734099 CMS
Allergan, Inc. $600.0007/10/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734095 CMS
Allergan, Inc. $1,250.0007/09/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734093 CMS
Allergan, Inc. $1,250.0007/02/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734091 CMS
Allergan, Inc. $1,250.0007/01/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734089 CMS
NEW WORLD MEDICAL,INC. $2,500.0007/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243101 CMS
Allergan, Inc. $300.0006/29/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734087 CMS
Allergan, Inc. $1,250.0006/26/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734085 CMS
Allergan, Inc. $400.0006/25/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734083 CMS
Allergan, Inc. $1,250.0006/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734081 CMS
Allergan, Inc. $1,250.0006/09/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734079 CMS
Allergan, Inc. $900.0006/07/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734077 CMS
Allergan, Inc. $1,250.0006/02/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734075 CMS
NEW WORLD MEDICAL,INC. $500.0005/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243097 CMS
NEW WORLD MEDICAL,INC. $1,000.0005/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243099 CMS
NEW WORLD MEDICAL,INC. $250.0005/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243111 CMS
NEW WORLD MEDICAL,INC. $500.0005/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243113 CMS
NEW WORLD MEDICAL,INC. $3,500.0005/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243117 CMS
NEW WORLD MEDICAL,INC. $3,500.0005/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243119 CMS
NEW WORLD MEDICAL,INC. $250.0005/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243123 CMS
NEW WORLD MEDICAL,INC. $375.0005/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243129 CMS
NEW WORLD MEDICAL,INC. $250.0005/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243133 CMS
NEW WORLD MEDICAL,INC. $750.0005/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243135 CMS
NEW WORLD MEDICAL,INC. $750.0005/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243137 CMS
Allergan, Inc. $1,250.0005/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734073 CMS
Allergan, Inc. $1,250.0005/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734071 CMS
Allergan, Inc. $600.0005/13/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734069 CMS
Allergan, Inc. $1,200.0004/29/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734067 CMS
Allergan, Inc. $750.0004/27/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734065 CMS
Allergan, Inc. $600.0004/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734063 CMS
Allergan, Inc. $900.0004/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734061 CMS
Allergan, Inc. $1,250.0004/17/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734059 CMS
Allergan, Inc. $1,500.0004/15/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734057 CMS
Reichert, Inc. $3,000.0004/07/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 712951893 CMS
Allergan, Inc. $300.0004/05/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734055 CMS
Allergan, Inc. $350.0004/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734051 CMS
Allergan, Inc. $400.0004/02/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734053 CMS
NEW WORLD MEDICAL,INC. $1,000.0004/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243125 CMS
NEW WORLD MEDICAL,INC. $1,500.0004/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243131 CMS
Allergan, Inc. $900.0003/31/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723734049 CMS
NEW WORLD MEDICAL,INC. $500.0003/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243115 CMS
NEW WORLD MEDICAL,INC. $2,000.0003/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753243127 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $128,526.74 153
PY2020 $146,053.16 132
PY2021 $111,005.40 103
PY2022 $82,031.92 115
PY2023 $91,266.25 103
PY2024 $89,681.54 96
PY2025 $56,387.47 89

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $10,000.00 1
PY2025 Principal investigator $77,851.31 25
PY2024 Principal investigator $73,835.05 24
PY2023 Recipient $8,375.00 1
PY2023 Principal investigator $48,900.38 24
PY2022 Recipient $48,562.50 3
PY2022 Principal investigator $106,553.58 16
PY2021 Principal investigator $110,595.00 15
PY2020 Recipient $10.13 1
PY2020 Principal investigator $47,418.87 13
PY2019 Recipient $30,375.00 1
PY2019 Principal investigator $160,999.99 24

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

26 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Glaukos Corporation $3,150.00 11/26/2025 Covered Recipient Teaching Hospital
Uh Cleveland Medical Center
Prospective, Multicenter Study of PRESERFLOMicroShunt in Subjects with Primary Open-AngleGlaucoma Who Have Failed Previous Medical and SurgicalTreatment No dispute reported 06/30/2026 1250910453
Principal investigator 1 ABBVIE INC. $4,642.00 11/05/2025 Non-covered Recipient Entity
GLAUCOMA ASSOCIATES OF TEXAS PA
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma No dispute reported 06/30/2026 1202522679
Principal investigator 1 Glaukos Corporation $525.00 10/22/2025 Covered Recipient Teaching Hospital
Uh Cleveland Medical Center
Prospective, Multicenter Study of PRESERFLOMicroShunt in Subjects with Primary Open-AngleGlaucoma Who Have Failed Previous Medical and SurgicalTreatment No dispute reported 06/30/2026 1250910455
Recipient NEW WORLD MEDICAL,INC. $10,000.00 10/14/2025 Covered Recipient Physician Investigator Initiated Study No dispute reported 06/30/2026 1246944379
Principal investigator 1 ABBVIE INC. $4,403.40 10/09/2025 Non-covered Recipient Entity
GLAUCOMA ASSOCIATES OF TEXAS PA
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma No dispute reported 06/30/2026 1202514609
Principal investigator 1 Glaukos Corporation $393.75 09/10/2025 Covered Recipient Teaching Hospital
Uh Cleveland Medical Center
Prospective, Multicenter Study of PRESERFLOMicroShunt in Subjects with Primary Open-AngleGlaucoma Who Have Failed Previous Medical and SurgicalTreatment No dispute reported 06/30/2026 1250910659
Principal investigator 1 Glaukos Corporation $90.00 09/10/2025 Covered Recipient Teaching Hospital
Uh Cleveland Medical Center
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250910835
Principal investigator 1 ABBVIE INC. $10,531.20 09/04/2025 Non-covered Recipient Entity
GLAUCOMA ASSOCIATES OF TEXAS PA
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma No dispute reported 06/30/2026 1202509088
Principal investigator 1 ABBVIE INC. $102.83 08/21/2025 Non-covered Recipient Entity
GLAUCOMA ASSOCIATES OF TEXAS PA
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma No dispute reported 06/30/2026 1202505467
Principal investigator 1 ABBVIE INC. $265.30 08/21/2025 Non-covered Recipient Entity
GLAUCOMA ASSOCIATES OF TEXAS PA
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma No dispute reported 06/30/2026 1202505469
Principal investigator 1 Glaukos Corporation $90.00 08/13/2025 Covered Recipient Teaching Hospital
Uh Cleveland Medical Center
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250910825
Principal investigator 1 ABBVIE INC. $28,296.00 08/06/2025 Non-covered Recipient Entity
GLAUCOMA ASSOCIATES OF TEXAS PA
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma No dispute reported 06/30/2026 1202503187
Principal investigator 1 Glaukos Corporation $270.00 07/16/2025 Covered Recipient Teaching Hospital
Uh Cleveland Medical Center
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250910815
Principal investigator 1 ABBVIE INC. $585.60 07/02/2025 Non-covered Recipient Entity
GLAUCOMA ASSOCIATES OF TEXAS PA
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma No dispute reported 06/30/2026 1202494165
Principal investigator 1 Glaukos Corporation $180.00 06/04/2025 Covered Recipient Teaching Hospital
Uh Cleveland Medical Center
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250910741
Principal investigator 1 ABBVIE INC. $585.60 05/07/2025 Non-covered Recipient Entity
GLAUCOMA ASSOCIATES OF TEXAS PA
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma No dispute reported 06/30/2026 1202483485
Principal investigator 1 Glaukos Corporation $2,490.00 05/07/2025 Non-covered Recipient Entity
Glaucoma Associates of Texas
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250910301
Principal investigator 1 Glaukos Corporation $540.00 04/29/2025 Covered Recipient Teaching Hospital
Uh Cleveland Medical Center
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250910805
Principal investigator 1 Glaukos Corporation $4,980.00 04/02/2025 Non-covered Recipient Entity
Glaucoma Associates of Texas
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250910297
Principal investigator 1 Glaukos Corporation $2,490.00 04/02/2025 Non-covered Recipient Entity
Glaucoma Associates of Texas
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250910299
Principal investigator 1 Glaukos Corporation $180.00 03/12/2025 Covered Recipient Teaching Hospital
Uh Cleveland Medical Center
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250910959
Principal investigator 1 Glaukos Corporation $1,245.00 02/12/2025 Non-covered Recipient Entity
Glaucoma Associates of Texas
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250910295
Principal investigator 1 ABBVIE INC. $10,093.00 02/06/2025 Non-covered Recipient Entity
GLAUCOMA ASSOCIATES OF TEXAS PA
M22-087 - A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma No dispute reported 06/30/2026 1202449373
Principal investigator 1 Glaukos Corporation $207.63 01/15/2025 Non-covered Recipient Entity
Precision Vision
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250907199
Principal investigator 1 Glaukos Corporation $1,245.00 01/08/2025 Non-covered Recipient Entity
Glaucoma Associates of Texas
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250910293
Principal investigator 1 Glaukos Corporation $270.00 01/08/2025 Covered Recipient Teaching Hospital
Uh Cleveland Medical Center
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study No dispute reported 06/30/2026 1250910953